© 2022 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
January 20, 2022
As the omicron variant continues to surge across the country, putting staff at many practices on edge, waning immunity may be driving an increase in virus infections.
January 20, 2022
The difference between retina’s biological age and person’s real age linked to heightened death risk, with a team of Australian investigators finding that evidence suggests the microvasculature in the retina may be a reliable indicator of the overall health of the body’s circulatory system and the brain.
January 20, 2022
According to the companies, the agreement will open a channel between federal health facilities and CorneaGen's laboratories.
January 19, 2022
Since joining the foundation in 2018, Menzo has been involved in the formation of the Retinal Degeneration Fund, the venture arm of Foundation Fighting Blindness.
January 17, 2022
A University of California Davis study shows that small serving of the fruit increased protective pigments in the eye.
January 14, 2022
According to the company, biped.ai includes a comfortable and lightweight collar fitted with 3d cameras that continuously monitor a 170° field of view for the user detecting, tracking and predicting the trajectories of all surrounding elements a few seconds in advance.
January 14, 2022
According to investigators, patients implanted with diffractive multifocal IOLs had notable declines in the corrected distance visual acuity, distance corrected near VA, and near area of focus with aging
January 13, 2022
According to the company, A197 is a novel, first-in-class, topical immunomodulatory agent which will move into Phase II clinical trials in dry eye patients.
January 13, 2022
The pivotal trial of MINIject, STAR-V, now initiated in 13 sites across the US, has received positive feedback from glaucoma surgeons involved in the trial.
January 13, 2022
Informed guidelines are needed to diagnose and treat COVID-19 patients with neurologic manifestations, according to investigators.